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NGS-based deep bisulﬁte sequencing
Suman Lee, Joomyeong Kim *
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA
G R A P H I C A L A B S T R A C T

A B S T R A C T

We have developed an NGS-based deep bisulﬁte sequencing protocol for the DNA methylation analysis of
genomes. This approach allows the rapid and efﬁcient construction of NGS-ready libraries with a large number of
PCR products that have been individually ampliﬁed from bisulﬁte-converted DNA. This approach also employs a
bioinformatics strategy to sort the raw sequence reads generated from NGS platforms and subsequently to derive
DNA methylation levels for individual loci. The results demonstrated that this NGS-based deep bisulﬁte
sequencing approach provide not only DNA methylation levels but also informative DNA methylation patterns
that have not been seen through other existing methods.
 This protocol provides an efﬁcient method generating NGS-ready libraries from individually ampliﬁed PCR
products.
 This protocol provides a bioinformatics strategy sorting NGS-derived raw sequence reads.
 This protocol provides deep bisulﬁte sequencing results that can measure DNA methylation levels and
patterns of individual loci.
ß 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).

Abbreviations: NGS, Next-Generation-Sequencing; PCR, polymerase chain reaction.
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Method details
Overview
DNA methylation on CpG dinucleotides is as an epigenetic modiﬁcation indicating the functional
status of a given locus in a cell type [1]. This epigenetic mark can be determined through the bisulﬁte
sequencing method, which involves a series of chemical reactions and subsequent sequencing of a
genomic region [2]. The bisulﬁte sequencing method has been traditionally used for measuring the
methylation levels of a small number of genomic regions in a targeted fashion. In recent years, this
bisulﬁte sequencing method has been adopted as a genome-wide approach owing to the
advancement of Next-Generation-Sequencing (NGS) platforms [3,4]. The NGS-driven bisulﬁte
sequencing is useful for providing a global view of epigenomes and also for identifying genomic loci
with different levels of DNA methylation. For a given locus, however, the majority of the NGS-driven
data are not sufﬁciently deep enough to report the reliable and comprehensive measurement of its
DNA methylation levels due to the relatively low levels of sequencing depth. This is particularly
problematic in a situation where a testing DNA is derived from a mixture of different types of cells
and/or functional status.
To solve this problem, we have developed a protocol in the current study (Fig. 1A). The main
objective of this protocol is NGS-based deep bisulﬁte sequencing of a relatively small number of
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Fig. 1. Overall scheme for NGS-based deep bisulﬁte sequencing. (A) The entire procedure of the NGS-based deep bisulﬁte
sequencing protocol is shown as a ﬂow chart. (B) The adaptor ligation step for the current protocol has adopted one strategy, in
which the added PCR products and two adaptors are ligated through two stepwise incubations. Since both adaptors lack the
phosphate group at their 50 -ends, the ligation reaction by T4 at 25 8C occurs between only one strand of the adaptors and the PCR
products. In this case, the phosphate groups are derived from the 50 -end of the PCR products. At 65 8C, the activated Bst2.0
WarmStart polymerase extends and displaces the other unligated strand from the partially joined products. The * symbol
indicates the phosphate group at the 50 -end of the end-repaired PCR products. (C) The sequences of Ion Torrent P1 and A
adaptors are shown with different colors to indicate the key, barcode and spacer regions. The * symbol indicates a phosphothiate
bonding between two nucleotides, which protects the duplex adaptor from being digested by the exonuclease activity of DNA
polymerases.
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genomic targets. The detailed procedure is as follows. In Step 1, this protocol pulls together a number
of ampliﬁed PCR products, size-ranging from 200 to 400 base pair (bp) in length. The selection of this
size range is based on the average read lengths that can be afforded by NGS platforms (here, Ion
Torrent PGM2). The number of PCR products that can be grouped together as a library ranges from
several hundreds to a few thousands. The DNA amount of individual PCR products needs to be
normalized for different target loci to be represented evenly well among the ﬁnal sequence reads from
NGS runs. In Steps 2 and 3, this library of PCR products goes through the end repair reaction followed
by size selection on a 2% agarose gel. In Step 4, the eluted DNA from the agarose gel is ligated to a set of
duplex adaptors that are compatible with NGS platforms (in our case, Ion Torrent P1 and A adaptor)
(Fig. 1B and C). During this step, multiplexing can be achieved with a set of A adaptors with different
barcodes (Supplemental material 1). This ligation step has been usually problematic in many cases of
library construction mainly due to the self-ligation reaction between two adaptors, which is the most
dominant among all combinations of ligations. To avoid this self-ligation problem, the current
protocol does not use phosphorylated adaptors. In this case, the phosphate groups are derived from
the 50 -ends of the end-repaired PCR products. The current protocol also uses a mixture of T4 ligase and
Bst2.0 WarmStart polymerase with two stepwise incubations, a 25-min incubation at 25 8C for the
ligation reaction by T4 ligase and another 30-min incubation at 65 8C for the extension/displacement
reaction by Bst2.0 WarmStart polymerase (available from NEB). The initial incubation ligates only one
strand, not both, of each 50 -end of PCR products to the adaptors (Fig. 1B). Once this type of partially
ligated products reaches to the 65 8C temperature, the activated Bst2.0 WarmStart polymerase
initiates the extension and displacement reaction on the other strand, which has not been ligated
earlier by T4 ligase. In Steps 5 and 6, the library of PCR products is then size-selected again on a 2%
agarose gel, and the eluted DNA is used for PCR ampliﬁcation with a set of the two primers that
correspond to the two adaptors. The typical cycle numbers for this step is between 10 and 14. In Step 7,
the library of ampliﬁed PCR products is used for sequencing on a desired NGS platform.
The current protocol uses a set of bioinformatic tools to process the output from NGS runs. Since
the initial library is made of a number of individual PCR products, the sequencing output from a NGS
run needs to be sorted as described below. First, if one of the adaptors is indexed with multiple
barcodes, the sequencing output will be sorted based on the used barcodes. Second, the sequencing
output is further sorted with the primer sequences for each PCR product using a custom Perl script
(Supplemental material 2). Finally, the sorted sequences for each PCR product are used for calculating
its DNA methylation levels with BiQ Analyzer HT [5]. A set of additional Perl scripts have been
prepared to execute the process of BiQ Analyzer HT on a batch mode (Supplemental material 2).
The current protocol uses a set of bioinformatic tools to process the output from NGS runs. Since
the initial library is made of a number of individual PCR products, the sequencing output from a NGS
run needs to be sorted as described below. First, if one of the adaptors is indexed with multiple
barcodes, the sequencing output will be sorted based on the used barcodes. Second, the sequencing
output is further sorted with the primer sequences for each PCR product using a custom Perl script
(Supplemental material 2). Finally, the sorted sequences for each PCR product are used for calculating
its DNA methylation levels with BiQ Analyzer HT [5]. A set of additional Perl scripts have been
prepared to execute the process of BiQ Analyzer HT on a batch mode (Supplemental material 2).
Reagents
A adapter primer
Oligo: CCATCTCATCCCTGCGTGTC
Barcode A Adapter (Fig. 1C)
Bst2.0 WarmStart DNA polymerase (includes 10 Isothermal Ampliﬁcation Buffer; New England
Biolabs. Cat. No. M0538S)
DNA Clean & ConcentratorTM-25 (includes spin columns, DNA Binding Buffer, Wash Buffer, Elution
Buffer, Zymo, Cat. No. D4005)
NEBNext End Repair Module (includes NEBNext End Repair Enzyme Mix, NEBNext End Repair
Reaction Buffer; New England Biolabs, Cat. No. E6050S)
P1 Adapter (Fig. 1C)

4

S. Lee, J. Kim / MethodsX 3 (2016) 1–7

P1 Adapter Primer
Oligo: CCACTACGCCTCCGCTTTCC
T4 DNA Ligase (includes 10 T4 DNA Ligase Reaction Buffer; New England Biolabs, Cat. No. M0202S)
TE buffer (1, pH 8.0)
Zymoclean Gel DNA Recovery Kit (includes spin columns, ADB Buffer, Wash Buffer, Elution Buffer;
Zymo, Cat. No. D4001)
Equipment

2100 Agilent Bioanalyzer System
Agarose gel (2%) and equipment for electrophoresis
Centrifuge (Benchtop centrifuge for 1.5 ml microcentrifuge tubes)
E-Gel Precast Agarose Electrophoresis System
Ion torrent PGM NGS machine
Thermocycler

Procedure
Library preparation procedure

1. Combine all the PCR products that have been ampliﬁed from bisulﬁte-converted DNA. It is
important to normalize the DNA amount of individual PCR products.
2. Prepare the end repair reaction as described below.
Component

Volume

PCR product
End repair enzyme mix
End repair reaction buffer (10)
H2O

X ml
5 ml
10 ml
Y ml

Total

100 ml

3. Incubate at 20 8C for 30 min in thermocycler.
4. Prepare a 2% agarose gel for size selection.
5. Load the entire DNA sample into one or two wells along with a 100-bp size marker in a separate
well, and run the gel at 100 V for 40 min.
6. Excise a section of the agarose gel containing the PCR products with the desired size range, and
extract the DNA from the gel using Zymoclean Gel DNA Recovery Kit. Finally, elute the DNA in
20 ml of TE.
7. Prepare the adapter ligation reaction as described below.
Component

Volume

Size selection sample
Bst2.0 warm polymerase (8000 U/ml)
Bst2.0 polymerase buffer (10)
T4 DNA ligase (400,000 U/ml)
T4 DNA ligase buffer (10x)
P1 + A Barcode Adapter (10 pmol/ml)

17 ml
1 ml
4 ml
4 ml
4 ml
10 ml

Total

40 ml

8. Incubate at 25 8C for 25 min, 65 8C for 30 min, and ﬁnally 80 8C for 20 min to stop the reaction.
9. Repeat the size selection step as described above (5–6). Elute the DNA sample in 10 ml of
D.W.
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10. Perform PCR to amplify the eluted DNA with a set of the two primers corresponding to P and A1
adapter: P1 adapter primer, 50 -CCACTACGCCTCCGCTTTCCTCT-30 ; A adapter primer, 50 -CCATCTCATCCCTGCGTGTCTCC-30 .
11. The detailed program for PCR is shown below. The typical number of PCR cycles ranges from 10 to
14.

12.
13.
14.
15.

Cycle number

Denature

Anneal

Extension

1
10–14
1

95 8C, 5 min
95 8C, 30 s

68 8C, 30 s

72 8C, 45 s
72 8C, 10 min

Clean up the ﬁnal PCR product using DNA Clean & Concentrator Kit.
Size select using E-Gel Precast Agarose Electrophoresis system.
Clean up the selected DNA library fragment using DNA Clean & Concentrator Kit.
Perform NGS-based sequencing with the prepared library.

Bioinformatics analysis
We used the following bioinformatics pipeline to process the raw sequence reads derived from a NGS
platform. This pipeline includes several custom-made Perl scripts along with Unix-based command lines.
This pipeline require two ﬁles in the text format: the ﬁrst ﬁle containing a list of names for individual
PCR products and the second ﬁle containing the sequences of all the primers used for the ampliﬁcation of
PCR products. This pipeline also requires a directory of the individual sequence ﬁles in the fasta format,
which correspond to the unconverted original sequences of the PCR products. This directory is used
later for calculating DNA methylation with BiQ Analayzer HT. The detailed steps are as follows:
(1) Remove raw sequence reads smaller than 100 bp in length and sort raw sequence reads into each
ﬁle based on their origin of PCR products with a custom Perl script (test_sam_3.pl). The execution
of this step generates a directory with a number of ﬁles containing the sorted sequence reads. Two
ﬁles are usually generated for a given PCR product since this sorting process uses the sequences of
the two primers that have been used to amplify the PCR product.
(2) Combine the two ﬁles that belong to a same PCR product with a custom Perl script (test_merge.pl).
(3) Execute BiQ Analyzer HT with a custom Perl script (test_biq.pl). This execution requires a tsv ﬁle
containing two sets of absolute directory paths. The ﬁrst set is for all of the original unconverted
sequence ﬁles for PCR products, whereas the second set is for all of the sorted bisulﬁte sequence
ﬁles. The tsv ﬁle can be prepared with a custom Perl script (test_tsv.pl).
(4) Extract the necessary information (the number of reads used, % methylation, standard deviation)
from the output of BiQ Analyzer HT with a custom Perl script (test_extract.pl).
The execution of these steps will ﬁnally derive one text ﬁle containing the DNA methylation level
for the entire set of PCR products, which can be imported into an excel ﬁle for further calculation and
inspection. The custom Perl scripts used for this process are presented in Supplemental material 2.

Method validation
So far, we have performed three independent trials of DNA methylation analyses using this
protocol [6]. These test trials have successfully derived the DNA methylation levels of on average 80%
of individual PCR products. While performing these trials, however, we have come across a couple of
technical issues, which may be responsible for the observed failure, the remaining 20% of the PCR
products. First, the initial DNA amounts of some of these PCR products were lower than those of the
other PCR products. As a consequence, the sequence reads from these products were not as well
represented as the other products in the ﬁnal sequencing output. It is, therefore, very important to
normalize the initial DNA amounts of individual PCR products at the early stage of library construction
(Step 1 in Fig. 1A). Also, it is advisable to perform an independent protocol, such as COBRA (Combined
Bisulﬁte Restriction Analysis) [7], before the actual bisulﬁte sequencing given the possibility that PCR
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could enrich one type of DNA sequences, such as unmethylated DNA compared to methylated DNA.
Second, the size of some of sequence reads turned out to be much smaller than their predicted sizes
based on the initial sizes of PCR products. According to detailed inspection, the sequences of these
products were truncated at homopolymeric regions, such as poly A or T. These are typical sequences
for bisulﬁte-converted DNA since many Cs are converted to Ts during the bisulﬁte conversion reaction.
According to our recent study [6], similar polymeric repeats are often detected in mammalian
genomes, 2 out of 12 ampliﬁed PCR products with the average length being around 300 bp in length.
Although the exact cause for this truncation is currently unknown, one culprit might be the potential
stalling and subsequent falloff of DNA polymerase from template DNA during the sequencing reaction
of NGS. One remedy to this problem may be avoiding homopolymeric regions while selecting target
regions. Also, different NGS platforms tend to have different success rates in coping with this problem,
thus one should consider this aspect more carefully for future projects.
Despite these technical shortfalls, the results from the successful runs with the remaining 80% of
the PCR products were very informative and insightful due to their overall deep sequencing coverage.
In a particular trial measuring the DNA methylation levels of 250 PCR products, we have obtained on
average 1000 sequence reads per each PCR product, which were subsequently used for measuring
DNA methylation levels with BiQ Analyzer HT. We performed two independent runs of NGS
sequencing to test the overall reproducibility of this protocol. One representative locus is presented in
Fig. 2. Human USP29 (Ubiquitin-speciﬁc protease 29) is an imprinted gene, yet frequently associated
with several human cancers as a potential tumor suppressor [8,9]. Thus, a set of PCR products targeting
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Fig. 2. DNA methylation levels and patterns of one representative data set. The NGS-based deep bisulﬁte sequencing protocol
was used to compare the DNA methylation levels of the promoter region of human USP29 between the individual samples of one
cancer DNA panel. This panel is comprised of the DNA isolated from two normal samples (brain and liver) and six cancer
samples (liver, breast, lung, ovary, colon, kidney). Two sets of the results were derived from two independent runs of NGS. The
numbers of raw sequence reads used for calculating the overall DNA methylation levels are shown underneath the name of each
sample. The image composed of a large number of blue and red boxes represents the graphic summary of DNA methylation
patterns. Each horizontal line represents one sequence read while each small box within this line indicates one CpG
dinucleotide. The blue and red boxes indicate the unmethylated and methylated CpG sites, respectively. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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the promoter of USP29 were ampliﬁed from a cancer DNA panel, which is made of two normal and six
cancer samples. As expected, the DNA methylation levels of the two normal samples (61.8 and 63.7%
for brain and 54.7 and 54.5% for liver) were lower than those from six cancer samples, which range
from 67.2% to 89.8%. The higher levels of DNA methylation levels observed in the cancer samples
further support the proposed tumor suppressor role for USP29. We observed less than 2% level
difference between two independent runs (normal brain, 61.8 vs 63.7%), conﬁrming the
reproducibility of the protocol. This type of measurements can be also obtained through the other
existing methods, such as Human450K array and pyrosequencing. However, the DNA methylation
patterns obtained through the current protocol cannot be obtained through the other methods,
although the other method, such as pyrosequencing, may provide more consistent methylation levels
in a given position. As seen in Fig. 2, the two normal samples display a somewhat allele-speciﬁc DNA
methylation pattern as an imprinted gene although the pattern from normal brain is mosaic. In
contrast, the results from the cancer samples display unexpected DNA methylation patterns. Several
patches of blue lines (representing unmethylated CpG sites) run through from bottom to top on the
background of a large number of small red boxes (representing methylated CpG sites). This is
particularly obvious in the two samples, liver and breast cancer samples. This indicates that several
CpG sites within the promoter region of USP29 are more resistant to DNA methylation in cancer
samples. Similar patterns have also been observed in the other PCR products targeting different
genomic loci (data not shown). Thus, the observed pattern appears to be an outcome of a previously
unnoticed general phenomenon in mammalian epigenomes, certain CpG sites being resistant to DNA
methylation. In conclusion, the current study demonstrated that the deep bisulﬁte sequencing by the
new protocol is a very useful approach that can provide many information for mammalian
epigenomes, including DNA methylation levels as well as patterns for a given locus.
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